| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |